Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
- Conditions
- Glaucoma Secondary to Eye InflammationNeovascular GlaucomaVascular Endothelial Growth Factor OverexpressionIntraocular Pressure
- Registration Number
- NCT04970251
- Lead Sponsor
- Siriraj Hospital
- Brief Summary
Purpose: To investigate intravitreal aflibercept (IVA) injection as an adjunctive treatment to trabeculectomy with mitomycin C (TMC) and panretinal photocoagulation (PRP) for neovascular glaucoma (NVG).
Setting: Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Study design: Prospective interventional case series Methods: PRP and IVA (2 mg/0.05 ml) injection were given, and TMC was performed within 2 weeks after IVA. Additional PRP, laser suture lysis, subconjunctival 5-fluorouracil injection, and bleb needling were performed after TMC if indicated. Best-collected visual acuity (BCVA), intraocular pressure (IOP), surgical complications, and number of anti-glaucoma medications were collected.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Consecutive patients with neovascular glaucoma who presented at the Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand during November 2018 to October 2019.
- Aged more than 18 year-old
- Patients who received any anti-vascular endothelial growth factor treatment before participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Intraocular pressure Post-operative on month 36th Intraocular pressure after trabeculectomy
- Secondary Outcome Measures
Name Time Method Visual acuity Post-operative on month 36th Visual acuity of the studied eye
Numbers of medication Post-operative on month 36th Numbers of anti-glaucoma medications
Trial Locations
- Locations (1)
Naris Kitnarong
🇹🇭Bangkoknoi, Bangkok, Thailand